News
Cancer Med Shortage Ends
06/24/2016
The US Food and Drug Administration (FDA) announced the resolution of a drug shortage that has gone on for more than a year.
Doxorubicin (Adriamycin) injection is now available in a number of presentations from Fresenius Kabi USA, Pfizer Pharmaceuticals, Sagent Pharmaceuticals, Sun Pharmaceuticals Industries, and Teva Pharmaceuticlas.
This shortage began in March 2015, according to an FDA report.
Click here to read the full list of available presentations.
--Stephanie Vaccaro
Reference:
US Food and Drug Administration. FDA drug shortages. www.fda.gov. Accessed June 23, 2016.
